Efficacy and Safety of a Dexamethasone Implant in Patients with Diabetic Macular Edema at Tertiary Centers in Korea

Journal of Ophthalmology

Volumn 2016, Issue , 2016, Pages

  Moon, Byung Gil ^a   Lee, Joo Yong ^a   Yu, Hyeong Gon ^b   Song, Ji Hun ^c   Park, Young Hoon ^d   Kim, Hyun Woong ^e   Ji, Yong Sok ^f   Chang, Woohyok ^g   Lee, Joo Eun ^h   Oh, Jaeryung ⁱ   Chung, Inyoung ^j  

^a University of Ulsan College of Medicine   (South Korea)

^b Seoul National University Hospital   (South Korea)

^c Ajou University School of Medicine   (South Korea)

^d The Catholic University of Korea   (South Korea)

^e Inje University College of Medicine   (South Korea)

^f Chonnam National University Medical School   (South Korea)

^g Yeungnam University Hospital   (South Korea)

^h Inje University   (South Korea)

ⁱ College of Medicine   (South Korea)

^j Gyeongsang National University   (South Korea)

more..

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84973376966     PISSN: 2090004X     EISSN: 20900058     Source Type: Journal    
DOI: 10.1155/2016/9810270     Document Type: Article

References (21)

1. J.W. Y. Yau, S. L. Rogers, R. Kawasaki et al., "Global prevalence and major risk factors of diabetic retinopathy," Diabetes Care, vol. 35, no. 3, pp. 556-564, 2012.
2. P. Mitchell, F. Bandello, U. Schmidt-Erfurth et al., "The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema," Ophthalmology, vol. 118, no. 4, pp. 615-625, 2011.
3. M. J. Elman, L. P. Aiello, R. W. Beck et al., "Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema," Ophthalmology, vol. 117, no. 6, pp. 1064-1077.e1035, 2010.
4. R. Karim and B. Tang, "Use of antivascular endothelial growth factor for diabeticmacular edema," ClinicalOphthalmology, vol. 4, no. 1, pp. 493-517, 2010.
5. L. P. Aiello, R. W. Beck, N. M. Bressler et al., "Rationale for the diabetic retinopathy clinical research network treatment protocol for center-involved diabetic macular edema," Ophthalmology, vol. 118, no. 12, pp. e5-e14, 2011.
6. M. W. Stewart, "Critical appraisal of ranibizumab in the treatment of diabetic macular edema," Clinical Ophthalmology, vol. 7, pp. 1257-1267, 2013.
7. J. A. Haller, B. D. Kuppermann, M. S. Blumenkranz et al., "Randomized controlled trial of an intravitreous dexamethasone drug delivery system in patients with diabetic macular edema," Archives of Ophthalmology, vol. 128, no. 3, pp. 289-296, 2010.
8. R. Herrero-Vanrell, J. A. Cardillo, B. D. Kuppermann, "Clinical applications of the sustained-release dexamethasone implant for treatment of macular edema," Clinical Ophthalmology, vol. 5, no. 1, pp. 139-146, 2011.
9. D. S. Boyer, Y. H. Yoon, R. Belfort et al., "Three-year, randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with diabetic macular edema," Ophthalmology, vol. 121, no. 10, pp. 1904-1914, 2014.
10. D. G. Callanan, S. Gupta, D. S. Boyer et al., "Dexamethasone intravitreal implant in combination with laser photocoagulation for the treatment of diffuse diabetic macular edema," Ophthalmology, vol. 120, no. 9, pp. 1843-1851, 2013.
11. S. B. Bressler, A. R. Edwards, K. V. Chalamet al., "Reproducibility of spectral-domain optical coherence tomography retinal thickness measurements and conversion to equivalent timedomain metrics in diabetic macular edema," JAMA Ophthalmology, vol. 132, no. 9, pp. 1113-1122, 2014.
12. M. L. Laursen, F. Moeller, B. Sander, A. K. Sjoelie, "Subthreshold micropulse diode laser treatment in diabetic macular oedema," British Journal of Ophthalmology, vol. 88, no. 9, pp. 1173-1179, 2004.
13. M. DutraMedeiros, M. Postorino, R. Navarro, J. Garcia-Aruḿ?, C. Mateo, B. Corcóstegui, "Dexamethasone intravitreal implant for treatment of patients with persistent diabetic macular edema," Ophthalmologica, vol. 231, no. 3, pp. 141-146, 2014.
14. P. Bansal, V. Gupta, A. Gupta,M. R. Dogra,J. Ram, "Efficacy of Ozurdex implant in recalcitrant diabetic macular edema-a single-center experience," International Ophthalmology, vol. 36, no. 2, pp. 207-216, 2016.
15. J. Chhablani, P. Bansal, D. Veritti et al., "Dexamethasone implant in diabetic macular edema in real-life situations," Eye, vol. 30, no. 3, pp. 426-430, 2015.
16. S. Guigou, S. Pommier, F. Meyer et al., "Efficacy and safety of intravitreal dexamethasone implant in patients with diabetic macular edema," Ophthalmologica, vol. 233, pp. 169-175, 2015.
17. M. C. Gillies, L. L. Lim, A. Campain et al., "A randomized clinical trial of intravitreal bevacizumab versus intravitreal dexamethasone for diabetic macular edema. The BEVORDEX Study," Ophthalmology, vol. 121, no. 12, pp. 2473-2481, 2014.
18. M. Scaramuzzi, G. Querques, C. L. Spina, R. Lattanzio, F. Bandello, "Repeated intravitreal dexamethasone implant (Ozurdex) for diabetic macular edema," Retina, vol. 35, no. 6, pp. 1216-1222, 2015.
19. D. S. Boyer, D. Faber, S. Gupta et al., "Dexamethasone intravitreal implant for treatment of diabetic macular edema in vitrectomized patients," Retina, vol. 31, no. 5, pp. 915-923, 2011.
20. M. D. Medeiros, M. Alkabes, R. Navarro, J. Garcia-Aruḿ, C. Mateo, B. Corcóstegui, "Dexamethasone intravitreal implant in vitrectomized versus nonvitrectomized eyes for treatment of patients with persistent diabetic macular edema," Journal of Ocular Pharmacology and Therapeutics, vol. 30, no. 9, pp. 709-716, 2014.
21. B. D. Kuppermann, C. Chou, D. V. Weinberg, S. M. Whitcup, J. A. Haller, M. S. Blumenkranz, "Intravitreous dexamethasone effects on different patterns of diabetic macular edema," Archives of Ophthalmology, vol. 128, no. 5, pp. 642-643, 2010.